ArticleCJC open2024

Safety of Continuing Trastuzumab for Mild Cardiotoxicity: A Cardiovascular Magnetic Resonance Imaging Study.

Sivisan Suntheralingam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.